Publications by authors named "Shuhui Deng"

Claim this Profile
S
Strychni Semen Improves Spatial Memory and Promotes Axon Regeneration Following Vascular Dementia in Mice.
Yan Zhang, Mengting Liu, Xinyue Zhao, Shuhui Deng, Zhuchen Zhou

Curr Neuropharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China.
Tingyu Wang, Yuting Yan, Hui Wang, Ying Sun, Xiantao Liu, Shuhui Deng

EClinicalMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.
Jingyu Xu, Meng Shu, Hsingwen Chung, Jian Cui, Yuntong Liu, Shuhui Deng

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.
Jian Cui, Jingwei Wang, Xiaoyun Li, Lina Wang, Xuehan Mao, Shuhui Deng

Adv Sci (Weinh)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.
Wenqiang Yan, Chen Qiu, Jieqiong Zhou, Jingyu Xu, Jian Cui, Shuhui Deng

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ID2 suppresses multiple myeloma cell proliferation by repressing the activity of the transcription factor TCF3.
Mariateresa Fulciniti, Yao Yao, Tommaso Perini, Jessica Fong Ng, Anaïs Schavgoulidze, Shuhui Deng

Blood Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.
Wenqiang Yan, Jiao Chang, Chenxing Du, Yuntong Liu, Rui Lv, Shuhui Deng

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.
Wei Liu, Ting Xie, Zhuoxin Zhang, Wenyang Huang, Huimin Liu, Shuhui Deng

Chin Med J (Engl)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma.
Chenxing Du, Jian Cui, Jingyu Xu, Wenqiang Yan, Lingna Li, Shuhui Deng

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Monoclonal Gammopathy of Undetermined Significance-Like (MGUS-like) Classifier Stratifies Prognosis in Multiple Myeloma: Results from Real-World Data in Chinese Population.
Wenqiang Yan, Jieqiong Zhou, Yuntong Liu, Jingyu Xu, Jian Cui, Shuhui Deng

Clin Lymphoma Myeloma Leuk· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the therapeutic potential of selective CDK7 and BRD4 inhibition against multiple myeloma cell growth.
Yao Yao, Shuhui Deng, Jessica Fong Ng, Mei Yuan, Chandraditya Chakraborty

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.
Wenqiang Yan, Yu Xiong, Rui Lv, Chenxing Du, Tengteng Yu, Shuhui Deng

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.
Wenqiang Yan, Lihui Shi, Jingyu Xu, Lingna Li, Jian Cui, Shuhui Deng

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.
Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies.
Shuhui Deng, Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martin

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features.
Hesong Zou, Wei Liu, Yi Wang, Dandan Shan, Ting Xie, Shuhui Deng

Chin Med J (Engl)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Shuhui Deng

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab plus cyclophosphamide and dexamethasone bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial.
Wenjie Xiong, Rui Lyu, Ying Yu, Tingyu Wang, Yuting Yan, Shuhui Deng

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.
Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Huishou Fan, Shuhui Deng

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
Lihui Shi, Wenqiang Yan, Jingyu Xu, Lingna Li, Jian Cui, Shuhui Deng

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Xuehan Mao, Wenqiang Yan, David Mery, Jiahui Liu, Huishou Fan, Shuhui Deng

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
Wei Liu, Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Shuhui Deng

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).
Huishou Fan, Bing Wang, Lihui Shi, Ni Pan, Wenqiang Yan, Shuhui Deng

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal genetically detectable minimal residual disease by fluorescence hybridization confers a poor prognosis in myeloma.
Jian Cui, Tengteng Yu, Rui Lv, Jiahui Liu, Huishou Fan, Shuhui Deng

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.
Huimin Liu, Hesong Zou, Dandan Shan, Wei Liu, Wenyang Huang, Shuhui Deng

Cancer Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis